Tube Investments of India to enter the pharmaceutical industry

Tube Investments of India (TII), a Murugappa group company, has identified contract development and manufacturing organisation (CDMO) and active pharmaceutical ingredients (API) as new lines of business with the ability to grow and expand. To that...

IIL, CIFA to commercially produce Aeromonas septicemia vaccine for freshwater fish

Indian Immunologicals Limited (IIL) announced a collaboration with the Central Institute of Freshwater Aquaculture (CIFA), Bhubaneswar, an Indian Council of Agricultural Research (ICAR) Institute, for the commercial development of a vaccine against..

Spanish packaging firm Inden Pharma to expand footprint in India

In order to strengthen their position in the worldwide pharmaceutical packaging market, the companies have agreed to begin certified production of bottles, containers, and closures in clean rooms in March. The companies intend to produce around...

Novartis launches new $11 billion share buyback

Novartis has formally launched its new share repurchase programme, which could cost up to 10 billion Swiss francs ($10.90 billion) over the next three years....

Agilent Technologies enters digital pathology scanner distribution agreement with Hamamatsu

Agilent Technologies Inc. announced a collaboration with Hamamatsu Photonics K.K., a prominent supplier of whole slide imaging systems, to integrate their NanoZoomer range, which includes the S360MD Slide scanner system, into the Agilent...

Top three challenges faced by Indian pharma companies in raw material procurement

Raw material procurement is a crucial part of the supply chain for pharma. The process can be highly complex, with multiple suppliers & overlapping supply chains.

Marksans Pharma Recieves Approval From US Health Regulator To Market Generic Version of Famotidine Tablets

Marksans Pharma Ltd announced on Friday that it has received final approval from the US Food and Drug Administration for its generic version of Famotidine tablets, which are used to treat acid indigestion and heartburn. The US Food and Drug Admini...

Bayer plans to spend $1 bln on US pharma drug R&D in 2023-US pharma head

Bayer AG plans to spend $1 billion on drug research and development in the United States this year as it seeks to double its sales in the country by the end of the decade, according to the company's top U.S. pharmaceutical executive....

U.S. FDA approves Amphastar Pharma's nasal spray for opioid overdose

Amphastar Pharmaceuticals Inc announced that the FDA had approved its nasal spray for the emergency treatment of known or suspected opioid overdose...

Grifols inks partnership and licensing pact with Selagine to develop immunoglobulin eye drops to treat dry eye disease

Grifols, one of the world’s leading producers of plasma-derived medicines, announced a global collaboration and licensing agreement with Selagine Inc, a company focused on developing novel therapeutics for ocular diseases, to treat dry eye disease...

© 2025 India Pharma Outlook. All Rights Reserved.